The unique activity of super-enhancers (SEs) has been implicated in SWI/SNF-mutant rhabdoid tumors, where SMARCB1-deficient SWI/SNF complex remains localized to SEs but not regular enhancers.15 The gene discussed is SMARCB1; the disease is rhabdoid tumor.